Business
Zomedica Expands TRUVIEW(R) and TRUFORMA(R) Intellectual Property Portfolio with Four Newly Issued U.S. Patents
Zomedica Expands TRUVIEW(R) and TRUFORMA(R) Intellectual Property Portfolio with Four Newly Issued U.S. Patents.
About this update from Zomedica Corp.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Zomedica Expands TRUVIEW(R) and TRUFORMA(R) Intellectual Property Portfolio with Four Newly Issued U.S. Patents\r\n \r\n \r\n\r\n\r\nZomedica Expands TRUVIEW(R) and TRUFORMA(R) Intellectual Property Portfolio with Four Newly Issued U.S. Patents\r\n\r\n\r\n\r\n\r\n\r\nIntellectual property portfolio now includes 228 Patents and 153 Trademarks providing robust protection for the Company's product platforms in the rapidly growing multi-billion dollar veterinary diagnostics market ANN ARBOR, MI / ACCESS Newswire / September 18, 2025 / Zomedica Corp. (OTCQB:ZOMDF) (\"Zomedica\" or the \"Company\"), an animal health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced the issuance of four additional U.S. patents protecting its TRUVIEW and TRUFORMA diagnostic platforms.\r\n These new patents significantly strengthen Zomedica's intellectual property portfolio and enhance the Company's ability to compete and capture share in the rapidly expanding veterinary diagnostics market-currently valued at $8-11 billion and projected to grow to $17-22 billion by 2030-2032 at a 9-11% CAGR (Fortune Business Insights; Grand View Research; Polaris Market Research).\r\n The United States Patent and Trademark Office recently issued patents numbered 12,405,192 B2, 12,399,092 B2, and 12,385,815 related to the TRUVIEW Microscope.. These patents are a continuation of U.S. Patent No. 11,422,073, \"Methods and Systems for Slide Processing,\" and cover proprietary automated systems that prepare and process diagnostic slides with precision.\r\n The TRUVIEW system utilizes micro-stream fluid dispensing, automated slide smearing, and integrated imaging to deliver consistent, laboratory-quality results at the point of care.\r\n On September 9, 2025, Zomedica was also issued U.S. Patent No. 12,411,110 B2, \"Crowded Sensor.\" This patent protects breakthrough acoustic wave sensor devices enhanced with crowding agents that slow analyte binding kinetics. By extending the window for detection, the technology may provide more accurate results and prevent saturation in high-concentration samples. This can facilitate multiplexed detection of both high- and low-abundance biomarkers in a single channel.\r\n With the addition of these patents, Zomedica now holds a total of 83 ...